FindTrial
Sign In

The effect Ferulic acid on metabolites of hydroxy bupropion by CYP2B6 and the POR gene

The effect Ferulic acid on metabolites of hydroxy bupropion by CYP2B6 and the POR gene

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001285
Enrollment
Unknown
Registered
2011-03-22
Start date
2011-03-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the POR gene

Interventions

Group A:none
Group B:none
Group C:none
Group D:none
Group E:none
Total:The effect Ferulic acid on metabolites of hydroxy bupropion by CYP2B6 and the POR gene

Sponsors

Institute of Clinical Pharmacology, Central South University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
16 Years to 27 Years

Inclusion criteria

Inclusion criteria: Genotyping

Exclusion criteria

Exclusion criteria: Person failed the physical examination

Design outcomes

Primary

MeasureTime frame
AUC of bupropion and hydrobupropion;Cmax of hydrobupropion;t1/2 of hydrobupropion;—

Countries

China

Contacts

Public ContactHonghao Zhou
hhzhou2003@163.com+86 731 84805380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 10, 2026